Figure S1. Triptolide did not alter the cell cycle distribution of HCC cells. a,b HepG2 and Hep3B cells were treated with indicated concentrations of triptolide for 12 hours. and Hep3B cells were treated with indicated concentrations of triptolide for 12 hours. Cell cycle analysis was performed using flow cytometry. c Protein levels of several cell cycle regulators were measured by western-blot. (TIFF 2606Â kb
Predicted target genes of group I C19MC miRNAs related to apoptosis. (DOCX 22 kb
Figure S2. The association between miR-490-3p expression and the prognosis in patients with HCC. (A1...
Table S3. Correlations of miR-296-5p expression with the clinicopathological features of HCC. (DOCX ...
Figure S2. Triptolide did not cause obvious liver or kidney damages in nude mice. a,b The concentrat...
Table S3. Clinicopathologic characteristics of HCC subtypes defined by miR-17 expression. (DOC 46Â k...
Figure S3. Triptolide reduced pri-miR-17-92 and pri-miR-106b-25 expression in vivo. Xenografted tumo...
Table S1 Primers used in this study. Table S2 Details of the CRC samples used in this study. Figure ...
Figure S6. MiRNA-21 mediates HSC activation. Cell contraction assay (a), Edu staining assay (b) and ...
Additional file 2: Table S1. List of potential tumor suppressors and oncogenes. Left; Tumor suppress...
Additional file 3: Figure S3. c-Myc represses growth, invasion and EMT of CRC cell by regulating miR...
Table S1. miR-302a/d and E2F7 expression and clinicopathological characteristics of 154 HCC patients...
Figure S2. MCM3AP-AS1 knockdown induced apoptosis of HCC cells. MCM3AP-AS1 knockdown increased the l...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Figure S3. Immunoblot showed that ATM expression was suppressed by overexpressing lentiviral miR-421...
Figure S3. MCM3AP-AS1 knockdown did not impact the growth of LO2 cells. LO2 cells were transfected w...
Predicted target genes of group I C19MC miRNAs related to apoptosis. (DOCX 22 kb
Figure S2. The association between miR-490-3p expression and the prognosis in patients with HCC. (A1...
Table S3. Correlations of miR-296-5p expression with the clinicopathological features of HCC. (DOCX ...
Figure S2. Triptolide did not cause obvious liver or kidney damages in nude mice. a,b The concentrat...
Table S3. Clinicopathologic characteristics of HCC subtypes defined by miR-17 expression. (DOC 46Â k...
Figure S3. Triptolide reduced pri-miR-17-92 and pri-miR-106b-25 expression in vivo. Xenografted tumo...
Table S1 Primers used in this study. Table S2 Details of the CRC samples used in this study. Figure ...
Figure S6. MiRNA-21 mediates HSC activation. Cell contraction assay (a), Edu staining assay (b) and ...
Additional file 2: Table S1. List of potential tumor suppressors and oncogenes. Left; Tumor suppress...
Additional file 3: Figure S3. c-Myc represses growth, invasion and EMT of CRC cell by regulating miR...
Table S1. miR-302a/d and E2F7 expression and clinicopathological characteristics of 154 HCC patients...
Figure S2. MCM3AP-AS1 knockdown induced apoptosis of HCC cells. MCM3AP-AS1 knockdown increased the l...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Figure S3. Immunoblot showed that ATM expression was suppressed by overexpressing lentiviral miR-421...
Figure S3. MCM3AP-AS1 knockdown did not impact the growth of LO2 cells. LO2 cells were transfected w...
Predicted target genes of group I C19MC miRNAs related to apoptosis. (DOCX 22 kb
Figure S2. The association between miR-490-3p expression and the prognosis in patients with HCC. (A1...
Table S3. Correlations of miR-296-5p expression with the clinicopathological features of HCC. (DOCX ...